Back to search
FDAFDA · Food and drugs·Recall number D-1387-2020

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Published July 22, 2020 · Recall initiated: June 29, 2020

Summary

FDA records drug Class II recall D-1387-2020, published July 22, 2020 and initiated June 29, 2020. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 498 tablets; Lot: Lot #: B0796217-020920, Exp. Date: 02/28/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product was distributed to MN.
Lot
Lot #: B0796217-020920, Exp. Date: 02/28/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose. recalled?

Yes. FDA published recall D-1387-2020 on July 22, 2020. Reported hazard: FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter